Auflistung Nach Schlagwort "blood clotting factor 10a"

Anzeige der Dokumente 1-2 von 2

Risk in atrial fibrillation: left atrial function matters

Triposkiadis F., Xanthopoulos A., Parissis J. (2019)

[No abstract available]
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

Hart R.G., Sharma M., Mundl H., Shoamanesh A., Kasner S.E., Berkowitz S.D., Pare G., Kirsch B., Pogue J., Pater C., Peters G., Davalos A., Lang W., Wang Y., Wang Y., Cunha L., Eckstein J., Tatlisumak T., Shamalov N., Mikulik R., Lavados P., Hankey G.J., Czlonkowska A., Toni D., Ameriso S.F., Gagliardi R.J., Amarenco P., Bereczki D., Uchiyama S., Lindgren A., Endres M., Brouns R., Yoon B.-W., Ntaios G., Veltkamp R., Muir K.W., Ozturk S., Arauz A., Bornstein N., Bryer A., O’Donnell M.J., Weitz J., Peacock F., Themeles E., Connolly S.J. (2016)

Background: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New Approach riVaroxaban Inhibition ...